AtriCure acquisition of SentreHEART : Afib device manufacturer AtriCure has agreed to acquire California-based medical device company SentreHEART in a deal worth up to about $300 million. Based in Ohio, AtriCure makes devices for the treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management. AtriCure’s Isolator Synergy Ablation System is the first and […]
Boston Scientific said that its LUMINIZE Radiofrequency (RF) Balloon Catheter (LUMINIZE RF Balloon Catheter), which is intended to be used for isolating pulmonary veins during treatment of patients with atrial fibrillation (AF), has achieved positive safety and efficacy results in the AF-FICIENT I clinical trial. Atrial fibrillation patients are usually treated with anti-arrhythmic drugs and […]
Continue reading …
Eiger bags FDA breakthrough therapy status for HDV drug candidate Lambda
NKMax America launches SNK01-MX03 clinical trial in plaque psoriasis
Mexican pharma company Sanfer secures $500m investment from CDPQ
Nabriva secures Xenleta FDA approval for community-acquired pneumonia
Celgene bags Inrebic FDA approval for myelofibrosis
Alfasigma USA launches IBS-C drug ZELNORM in US
AbbVie secures Rinvoq FDA approval for rheumatoid arthritis
FDA approves CVRx Barostim Neo System for advanced heart failure symptoms
Bio-Thera Solutions begins phase 1 trial for Simponi biosimilar BAT2506
Neuropore gets FDA orphan drug designation for NPT520-34 for ALS
Business News Today
